![Page 1: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/1.jpg)
PETER DINES Life Science Fundraising
![Page 2: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/2.jpg)
What do Investors look for?
Mercia Technologies 2016
• Who am I and what is Mercia?
• What to focus on and what not to do?
![Page 3: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/3.jpg)
The Complete Capital Model
Mercia Technologies 2016
Who am I?
![Page 4: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/4.jpg)
6Mercia Technologies 2016
Mercia Technologies’ is a leading player in the creation, funding and development of high growth technology businesses
throughout the UK, focused on:
Sector Focus
Regional Focus
Complete Capital
SolutionBuild & Delivery
Mercia Focus
![Page 5: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/5.jpg)
Investment Approach
£10k
to £150k
£80k
to £1m
£0.5m
to £2m
£1m
to £5m
Scale
Exit
MFM
MFM
Mercia
Technologies
Mercia
Technologies
Review and proactively seek companies in four core areas of focus
Business criteria
Perform due diligence
Determine whether to invest
Provide:
Infrastructure
Incubator and management
support
Flexible capital
Accelerate development & growthFast-track investment in best businesses
Strengthen the organisation to embrace scale
Grow customer base and partnerships
Accelerate value creation
Exit at most beneficial point
Pathfinder
& Seed
Early stage &
Development
Mercia Technologies 2016
![Page 6: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/6.jpg)
Mercia Technologies 2016 12
Investment Model
NEW AHSN FUND
![Page 7: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/7.jpg)
Mercia Technologies 2016
What is your core technology?
• USP• Intellectual Property• Barriers to entry
![Page 8: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/8.jpg)
Mercia Technologies 2015
What is the market opportunity?
• Addressable market ££• Competition• Route to market
• Reimbursement• Regulatory
![Page 9: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/9.jpg)
Mercia Technologies 2015
• Management• Management• Management
![Page 10: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/10.jpg)
Importance of Leadership
Mercia Technologies 2015
*** PATRICK LENCIONI - Mandatory reading for all leaders and entrepreneurs!!!
![Page 11: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/11.jpg)
What are you going to measure?
Mercia Technologies 2015
SALES
EBITDA
CASH FLOW
CUSTOMER EXPERIENCE
YOU CAN’T MANAGE WHAT YOU DON’T MEASURE
Product Development
Milestones
SALES PIPELINE
CUSTOMER SATISFACTIONOther KPI’s
![Page 12: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/12.jpg)
Optimist vs Healthy Cynic!!
Mercia Technologies 2015
§
![Page 13: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/13.jpg)
What is the funding requirement?
Mercia Technologies 2016
![Page 14: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/14.jpg)
What is the likely exit?
Mercia Technologies 2016
• IPO• Trade Sale• Who is likely acquirer?• What are the returns?
![Page 15: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016](https://reader035.vdocuments.us/reader035/viewer/2022070514/58800e031a28ab421b8b6619/html5/thumbnails/15.jpg)
Funding Options?
Mercia Technologies 2016
• Friends and Family• Grants• Regional/European Funding• Angel Investment• Investment Company
(EIS/VCT)• Corporate Investor